Search

Author/Creator Tashi, T.

1. P1049: A PHASE 2 STUDY OF BEZUCLASTINIB (CGT9486), A NOVEL, HIGHLY SELECTIVE, POTENT KIT D816V INHIBITOR, IN ADULTS WITH ADVANCED SYSTEMIC MASTOCYTOSIS (APEX): METHODS, BASELINE DATA, AND EARLY INSIGHTS. (23rd June 2022)

Authors:
DeAngelo, D. J.; Pullarkat, V.; Piris-Villaespesa, M.; George, T. I.; Patel, J. L.; Ustun, C.; Bose, P.; Heaney, M. L.; Pilla, A.; Massaro, M.; Exter, B.; Jolin, H. A.; Mikhak, Z.; Tashi, T.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
939
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search